Activation of alveolar macrophages via the alternative pathway in herpesvirus-induced lung fibrosis

Ana L Mora1, Edilson Torres-González, Mauricio Rojas

  • 1Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Center for Translational Research of the Lung, Emory University, 615 Michael Street Suite 215, Atlanta, GA 30322, USA. amora@emory.edu

Insights

Idiopathic pulmonary fibrosis (IPF) may be triggered by viruses. Our study shows virus-induced arginase I upregulation in lung macrophages and fibroblasts drives fibrogenesis, offering a potential mechanism for IPF development.

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Virology

Background:

  • The cause of idiopathic pulmonary fibrosis (IPF) remains unknown.
  • Viral pathogenesis is a suspected contributor to IPF.
  • Alveolar macrophages are implicated in the profibrotic response in human IPF.

Purpose of the Study:

  • To investigate the role of alveolar macrophages in a murine model of progressive pulmonary fibrosis.
  • To explore the potential mechanism of virus-induced lung fibrogenesis.

Main Methods:

  • Established a murine model of pulmonary fibrosis by infecting IFN-gammaR-deficient mice with murine gamma-herpesvirus 68.
  • Utilized immunohistochemistry, Western blot, and RT-PCR to analyze macrophage activation markers.
  • Examined lung tissue from IPF patients and control subjects.

Main Results:

  • Chronic herpesvirus infection led to alveolar macrophage recruitment and fibrotic changes.
  • Recruited macrophages exhibited markers of alternative activation, including high arginase I expression.
  • Increased arginase I expression and activity were observed in infected murine lungs and in IPF patient lung tissue.

Conclusions:

  • Virus-induced upregulation of arginase I in lung cells may be a key mechanism driving fibrogenesis in IPF.
  • This study provides insights into the role of macrophages and viral triggers in pulmonary fibrosis development.

Related Concept Videos

Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...